ARCHIVES

Addition of Cobimetinib Boosts PFS in BRAF Mutation-Positive Patients in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Kennedy Plans One Year Act Renewal, Followed By Three Year Bill; Hearing Scheduled Feb. 8

February 3, 1978

BRCA 1 Mutation Finding Draws Attention To Potential Perils Of Genetic Testing

October 6, 1995

Congressional Report Says NCI Ignored Das, Procedure, In Charges To Screening Guidelines

November 4, 1994

FDA orders “limited distribution” for lung cancer drug Iressa.

June 24, 2005

More Minorities, Women, Fewer MD On Study Sections

September 2, 1988

ASCO Honors Holland, Koop, Monaco With Special Awards

June 11, 1993